Form D · Biotechnology
Tobira Therapeutics, Inc.
Manalapan, NJ · CIK 0001409690
Offering snapshot reported Aug 30, 2010 · SEC filing
- Reported sold
- $14.2M Offering amount: $31.2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 24, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 30, 2010 | Initial | $14,199,776 | No comparison | 6 | SEC filing |
| Jul 14, 2010 | Initial | $4,999,999 | No comparison | 5 | SEC filing |
| Mar 11, 2010 | Initial | $4,000,000 | No comparison | 5 | SEC filing |
| Aug 10, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-147084
Source: Form D, filed Aug 30, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carol Brosgart | Director |
| Laurent Fischer | Director |
| Brian Halak | Director, Executive |
| Patrick Heron | Director |
| Michael Kamdar | Director |
| Kathleen Mc Gowan | Executive |
| James Sapirstein | Director, Executive |
| Daniel Turner | Director |
| Eckard Weber | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
198 Us Highway 9 North Suite 200
Manalapan, NJ, 07726
Manalapan, NJ, 07726